Source: https://patents.google.com/patent/US8444611B2/en
Timestamp: 2019-04-25 07:30:51
Document Index: 623442558

Matched Legal Cases: ['§119', 'Application No. 60', 'Application No. 200480020083', 'Application No. 200480020083', 'Application No. 04', 'Application No. 04', 'Application No. 544731', 'Application No. 200804990']

US8444611B2 - Negative pressure wound treatment dressing - Google Patents
US8444611B2
US8444611B2 US10/895,700 US89570004A US8444611B2 US 8444611 B2 US8444611 B2 US 8444611B2 US 89570004 A US89570004 A US 89570004A US 8444611 B2 US8444611 B2 US 8444611B2
US10/895,700
US20050020955A1 (en
2004-07-21 Application filed by KCI Licensing Inc filed Critical KCI Licensing Inc
2004-07-21 Priority to US10/895,700 priority patent/US8444611B2/en
2004-09-01 Assigned to KCI LICENSING, INC. reassignment KCI LICENSING, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SANDERS, TERYL BLANE, WILKES, ROBERT
2005-01-27 Publication of US20050020955A1 publication Critical patent/US20050020955A1/en
2008-05-30 Assigned to KCI INTERNATIONAL, INC., KINETIC CONCEPTS, INC., KCI LICENSING, INC., KCI USA, INC., KCI HOLDING COMPANY, INC. reassignment KCI INTERNATIONAL, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CITIBANK, N.A.
2010-03-24 Priority claimed from US12/730,582 external-priority patent/US20100210986A1/en
2012-11-18 First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34102854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US8444611(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
2013-05-21 Publication of US8444611B2 publication Critical patent/US8444611B2/en
A wound treatment dressing for applying negative pressure wound therapy to a wound on an extremity, such as on the heel of a foot. The dressing includes a fluid manifold positioned within a fenestrated drape to form a contoured occlusive wrapping. A contoured porous pad is placed adjacent or within the wound, and is covered by the occlusive wrapping. Flexible tubing is attached to or through a port to allow fluid communication of negative pressure to the contoured pad from a source of negative pressure. The negative pressure is communicated from the source, through the tube, through the fluid manifold, and through the fenestrations of the occlusive wrapping, to the wound. The fluid manifold conducts the negative pressure from a position away from the wound site to the contoured pad at the wound site.
This application claims the benefit under Title 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 60/489,344 filed under 37 C.F.R. 1.53(b)(2) on Jul. 22, 2003.
This invention relates to the treatment of open, chronic wounds, as well as burns and skin grafts. More specifically this invention relates to dressings for the treatment of wounds to the extremities, such as the heel of a human foot, by means of negative pressure wound therapy.
Negative pressure wound therapy has been utilized for the treatment of open wounds and has been commercialized by Kinetic Concepts, Inc. of San Antonio, Tex., by its proprietary V.A.C.® product line. In practice, the application to a wound of negative gauge pressure, as commercialized by Kinetic Concepts, Inc. under the designation “VACUUM ASSISTED CLOSURE” (or “V.A.C.”) therapy, typically involves the mechanical-like contraction of the wound with simultaneous removal of excess fluid, which is often accomplished by means of a polymer foam and occlusive drape dressing in fluid communication with a negative pressure source. In this manner, negative pressure wound therapy augments the body's natural inflammatory process while alleviating many of the known intrinsic side effects, such as the production of edema caused by increased blood flow absent the necessary vascular structure for proper venous return. As a result, negative pressure wound therapy has been highly successful in the promotion of wound closure, healing many wounds previously thought largely untreatable.
Many of these wounds include decubitus and venous stasis ulcers to the lower extremities, especially the foot. Closure of these wounds has been difficult and often times impossible using traditional techniques, such as skin grafting, sharp debridement, or combinations thereof. Failure to close these wounds, which have often been present for several years, can lead to necrotizing of the tissue, and in many cases amputation of the extremity. Use of negative pressure wound therapy has proven highly successful in closing these wounds. However, treatment of the lower extremities with negative pressure wound therapy, especially to wounds of the foot and heel can be difficult, especially considering the nature of the location of the wound. Particular concern arises with maintaining the dressing on the extremity, especially in light of the frequent movement of the foot, and friction often associated with foot coverings, including socks, stockings, and shoes. Of particular concern, is the ability to maintain a negative pressure at the wound site when the dressing is in place, as air leaks may occur during movement of the foot, which can adversely affect the therapy being administered.
For the foregoing reasons, there is a need for a negative pressure wound treatment dressing system that is capable of maintaining a negative pressure over an extremity that has heretofore been difficult to treat using traditional negative pressure wound therapy dressings. Additionally, there is a need for a negative pressure wound treatment dressing system that is capable of maintaining a negative pressure over a wound which exists in a highly contoured part of the body, or a portion of the body that undergoes frequent movement or friction against clothing or other outside forces.
It is therefore an object of the present invention to provide a negative pressure wound treatment dressing system that provides a means for maintaining a negative pressure over a contoured extremity, such as the foot, and more specifically the heel of the foot.
In accordance with the foregoing objects, the present invention generally comprises a fenestrated and contoured occlusive wrapping having a fluid manifold, a receiving site, fluid communicator arms extending from the receiving site, and an occlusive drape enclosing the fluid manifold. The occlusive drape generally includes a wound facing inner drape and an outward facing outer drape, and an aperture substantially aligned with the receiving site. A concave porous pad is placed adjacent or within a wound on an extremity, such as the heel of a foot, and is covered by the occlusive drape. Flexible tubing may be attached to or through the aperture, so as to allow for fluid communication of negative pressure to the porous pad from a source of negative pressure connected to an opposite end of the flexible tubing. The negative gauge pressure is communicated from the source, through the tube, through the fluid manifold in the occlusive drape, and through fenestrations in the occlusive drape, such that negative gauge pressure is applied to the wound. The fluid manifold serves to conduct the negative pressure from a position away from the wound site to the contoured porous pad at the wound site. Such an arrangement allows for the tubing to connect to the occlusive drape of the present invention at a position least likely to be dislodged during normal ambulation of the patient.
Attachment means are formed on the outer edges of the occlusive drape to form an airtight seal over the wound. Such attachment means may be an adhesive coated on the occlusive drape for attachment to an intact area of tissue or skin. The adhesive is coated on the perimeter edge of the occlusive drape such that a pouch is formed when the occlusive drape is secured over the porous pad.
A collection canister is provided between the negative pressure source and the occlusive drape for collecting any effluents that may be drawn from the wound during application of negative pressure.
The tubing is connected to the occlusive wrapping and pad through an aperture in the outer layer of the wrapping, or through a flanged tubing connector as has been described in U.S. Pat. No. 6,345,623, entitled “Surgical drape and suction head for wound treatment,” to Heaton, et al., the disclosure of which is incorporated herein by reference as though fully set forth. Alternative embodiments allow the tubing to be placed within or embedded in the fluid manifold.
FIG. 1A, is an exploded view of the occlusive wrapping of the present invention.
FIG. 1B is an orthogonal front view of the assembled occlusive wrapping of FIG. 1A, shown partly in section.
FIG. 2 is an orthogonal front view of a fluid manifold of FIG. 1A.
FIG. 3A is a perspective view of a contoured porous pad of the present invention.
FIGS. 3B and 3C are cross-sectional views of the contoured porous pad of FIG. 3A taken along section lines 3B-3B and 3C-3C, respectively, in FIG. 3D.
FIG. 3D is a top plan view of the contoured porous pad of FIG. 3A.
FIGS. 4A-4G are perspective views of the negative pressure wound treatment dressing system, illustrating the steps of applying the dressing system to a wound on the heel of a foot.
FIG. 5 is an orthogonal side view of the occlusive wrapping of FIG. 1B folded along its center line.
The details of the preferred embodiments of present invention are graphically and schematically illustrated in the accompanying drawings. Like elements in the drawings are represented by like numbers, and any similar elements are represented by like numbers with a different lower case suffix.
Referring now to FIGS. 1A and 1B in particular, there is illustrated the primary components of the occlusive wrapping 10 of the negative pressure dressing system that operates in accordance with the present invention. The occlusive wrapping 10 includes of a fluid manifold 14 enclosed within inner drape 16 a and an outer drape 16 b. Each of these drapes 16 a and 16 b are preferably made of a clear vapor permeable polyurethane material. The wound facing layer of inner drape 16 a and the outward facing layer of outer drape 16 b are sealed along their periphery to secure the fluid manifold 14 between the inner drape 16 a and the outer drape 16 b. Inner drape 16 a includes fenestrations 19 in a wound contact region 17, so as to allow for fluid communication through the inner drape 16 a to the fluid manifold 14. Outer drape 16 b includes an aperture 16 c substantially aligned with receiving site 20, through which tubing may fluidly communicate with the receiving site 20 of the fluid manifold 14, so as to allow for fluid communication of negative pressure to a porous pad from a source of negative pressure connected to an opposite end of the tubing (as shown in FIG. 4G). The fluid manifold 14 illustrated in FIG. 1A provides an extension region 21 and fluid communicator arms 22 that allows for attachment of a fluid communication port (not shown) at a position away from the wound site. The type of wounds desired to be treated by the present system are often situated at a position that has, at times, been difficult to maintain a reduced pressure using traditional negative pressure wound therapy techniques described herein. The occlusive wrapping 10 of the present invention overcomes this difficulty by communicating the negative pressure along the fluid manifold 14 of the occlusive wrapping 10. FIG. 1B shows essentially the same components of the occlusive wrapping 10 as shown in FIG. 1A. In this view of FIG. 1B from the wound side of the wrapping, wound contact region 17 on inner drape 16 a (shown partly in section) is shown to be bordered by portions of outer drape 16 b covered over with removable liner components 35, as well as second removable liner 37. Protective liner 36 (only minimally exposed in this view by partial section of inner drape 16 a and outer drape 16 b) supports outer drape 16 b of occlusive wrapping 10.
FIG. 2 illustrates the fluid manifold 14. As described above, the fluid communication port (not shown) of the overall system is adapted to be attached to a receiving site 20 of the manifold 14. The receiving site 20 is most preferably a circular shaped foam section of the manifold 14 that is approximately the size of the fluid communication port. Fluid communicator arms 22 extend distally from the receiving site 20 area of the fluid manifold 14 into the wound contact regions 17. In the embodiment illustrated in FIG. 2, the extension region 21 is interposed between the receiving site 20 and the fluid communicator arms. The fluid communicator arms 22 in a first embodiment terminate in loops 24, having openings for viewing the wound perimeter when, as in the preferred embodiment, inner and outer drapes 16 a and 16 b comprise a transparent material. In an alternative embodiment (not shown), fluid communicator arms 22 may terminate in fingers that extend distally from the fluid communicator arms 22 without forming loops.
A contoured pad 26 as illustrated in FIGS. 3A-3D is utilized as a wound contact screen to prevent unwanted adhesions, direct fluid away from the wound through pores within the pad 26, and exert contracting forces on the wound margins as negative pressure is applied through the manifold 14 and to the pad 26. The contoured pad 26 and fluid manifold 14 of the occlusive wrapping 10 are preferably made of a porous polymer foam material, such as polyurethane or polyvinyl alcohol foam. The pad 26 is preferably constructed into an elliptical shape as illustrated in FIG. 3D, but may also be more symmetrically circular to accommodate more uniform wounds.
In practice, the contoured pad 26 is trimmed to the areal dimensions of the wound and is placed in the wound, which may be on the heel of a foot, and between the wound and the fluid manifold 14, as illustrated in FIGS. 4A-4G. The pad 26 may be secured to the wound site by an adhesive strip 28, as shown in FIG. 4A, or by other means known in the art. In the preferred embodiment, the adhesive strip is constructed of the same vapor permeable polyurethane material as the inner and outer drapes 16 a and 16 b of the occlusive wrapping 10 having an adhesive coated on one side for securing the strip to the pad 26 and the intact skin surrounding the wound.
The occlusive wrapping 10 forms a pouch 30 when it is folded along its centerline and the lower edges 31 are bonded together at 33 as shown in FIG. 5. In practice, the pouch 30 is placed over the wound and contoured pad 26, as illustrated in FIGS. 4B and 4C. A fingerhold 39 is provided as an extension of protective liner 36 to facilitate grasping the pouch 30 and holding it in place as the removable liner components 35 are removed to expose adhesive backing on outer drape 16 b. The edges 32 a and 32 b (shown in FIG. 4B) of the pouch 30 are brought into contact with the intact skin surrounding the wound by means of this adhesive backing. A removable liner 35 (visible through the partial section of protective liner 36) is pulled off, for example, starting at finger tab extension 41 of removable liner 35 (shown bent back for grasping in FIG. 5), exposing the adhesive, as shown in FIG. 4C. The removable liners 35 may be statically adhered to the adhesive backing on outer drape 16 b to protect the adhesive during handling.
As illustrated in FIGS. 4D and 4E, a second removable liner 37 is adhered to the wound facing inner drape 16 a to protect the adhesive on the wound facing inner drape 16 a. The liner 37 is removed prior to adhesion of the wound facing inner drape 16 a to a region 40 of intact skin away from the wound site, so as to help prevent dislodgement of the fluid communication port 18 (shown in FIG. 4G) during movement of the patient. Protective liner 36 in a preferred embodiment, is overlaid on the outer drape 16 b (as illustrated in FIG. 1), so as to provide partial rigidity to the occlusive wrapping 10 and its fluid manifold 14 during handling. The liner 36 is removed after securing the pouch 30 to the wound site, as shown in FIG. 4F.
Reference is finally made to FIG. 4G which shows how a fluid communication port 18 is positioned over the receiving site 20, and is secured in place also by means of an adhesive contact surface on the communication port 18. As known in the art of negative pressure wound therapy, a fluid communication means 42, such as a flexible silicone tube, communicates negative pressure to the wound from a negative pressure source 44, such as a portable pump. A collection canister 46 is positioned in line between the negative pressure source 44 and the fluid communication means 42 to collect any exudates that may be drawn from the wound.
1. A wound dressing for use under negative pressure, the wound dressing comprising:
a fluid manifold having a receiving site and fluid communicator arms extending from the receiving site;
a drape formed from an occlusive material and having an inner drape and an outer drape enclosing the fluid manifold, and an aperture formed on the outer drape that is substantially aligned with the receiving site, and wherein the inner drape includes a plurality of fenestrations in a wound contact region substantially aligned with the fluid communicator arms; and
further comprising an extension region interposed between the receiving site and fluid communicator arms.
2. The wound dressing of claim 1, wherein the drape further comprises lower edges bonded together to form a pouch, and further comprising a porous pad positioned in the pouch.
3. The wound dressing of claim 2, wherein the porous pad comprises a concave porous pad formed from polyurethane.
4. The wound dressing of claim 1, wherein said fluid communicator arms terminate in contiguous loops.
5. A wound dressing for use under negative pressure, comprising:
a concave porous pad adapted for placement on a wound;
a clear drape formed from an occlusive material and adapted for positioning over and around the concave porous pad, wherein said clear drape encloses said fluid manifold, an adhesive on at least an edge of said clear drape for sealing said at least a portion of said clear drape to an area surrounding the wound, and a plurality of fenestrations formed on the clear drape; and
wherein said fluid communicator arms terminate in loops to allow viewing of the area around the wound through the clear drape.
6. The wound dressing of claim 5, wherein said clear drape is comprised of a wound faceable layer and an outer layer.
7. The wound dressing of claim 6, wherein said plurality of fenestrations are formed on the wound faceable layer for communicating fluid from the wound to said fluid manifold.
8. A wound dressing for use under negative pressure, comprising:
a concave porous pad adapted for placement in a wound;
a wrapping adapted for positioning over and around the concave porous pad, wherein said wrapping comprises a fluid manifold, a clear drape formed from an occlusive material and enclosing said fluid manifold, and an adhesive on at least an edge of said drape for sealing said wrapping to an area surrounding the wound;
said fluid manifold comprising a receiving site, an extension region, and a fluid communicator arm, said receiving site distal to and in flow communication with said fluid communicator arm through said extension region, and wherein said fluid communicator arm is comprised of a plurality of contiguous loops to allow viewing of the area around the wound through the clear drape;
wherein said clear drape is comprised of a wound faceable layer and an outer layer;
wherein said wound faceable layer is fenestrated for communicating fluid from the wound to said fluid manifold; and
wherein the wrapping further comprises lower edges bonded together to form a pouch.
US10/895,700 2003-07-22 2004-07-21 Negative pressure wound treatment dressing Active 2025-12-14 US8444611B2 (en)
US10/895,700 US8444611B2 (en) 2003-07-22 2004-07-21 Negative pressure wound treatment dressing
US12/730,582 US20100210986A1 (en) 2003-07-22 2010-03-24 Negative pressure wound treatment dressings and systems
US14/297,234 US20140283847A1 (en) 2003-07-22 2014-06-05 Negative pressure wound treatment dressings and systems
US12/730,582 Continuation-In-Part US20100210986A1 (en) 2003-07-22 2010-03-24 Negative pressure wound treatment dressings and systems
US20050020955A1 US20050020955A1 (en) 2005-01-27
US8444611B2 true US8444611B2 (en) 2013-05-21
US10/895,700 Active 2025-12-14 US8444611B2 (en) 2003-07-22 2004-07-21 Negative pressure wound treatment dressing
US20140200535A1 (en) * 2013-01-16 2014-07-17 Kci Licensing, Inc. Manually-actuated reduced pressure treatment system with audible leak indicator
CA2609104C (en) * 2007-04-10 2017-09-05 Exist Marketing Pty Ltd Method and device for treating bursitis
"Guidelines for Managing Pressure Ulcers with Negative Pressure Wound Therapy", a Supplement of Advances in Skin & Wound Care, vol. 17, Suppl. 2, Nov./Dec. 2004.
Arcand, "Negative Pressure Wound Therapy and its Application to Orthopaedics. Part II: Clinical Application", Osteo Trauma Care 2006; 14:254-258.
Armstrong, "Plantar Pressure Changes Using a Novel Negative Pressure Wound Therapy Technique", Journal of the American Podiatric Medical Association, Sep./Oct. 2004, vol. 94. No. 5, pp. 456 460.
Chinese Office Action issue date Dec. 11, 2009; Chinese Application No. 200480020083.5.
Chinese Office Action mailed Sep. 4, 2008; Chinese Application No. 200480020083.5.
Culliford, "A Novel Technique for Vacuum Assisted Closure Device Application in Noncontiguous Wounds", Journal of Plastic, Reconstructive & Aesthetic Surgery 2006.
European Official Action dated Apr. 30, 2008; European Application No. 04 778 864.1.
European Search Report dated Feb. 7, 2008; European Application No. 04 778 864.1.
Final Office Action date mailed Nov. 9, 2010 for U.S. Appl. No. 12/006,566.
International Search Report and Written Opinion date mailed Feb. 19, 2009; PCT Application No. PCT/US2008/088635.
K.F. Jeter, T.E. Tintle, and M. Chariker, "Managing Draining Wounds and Fistulae: New and Established Methods,"Chronic Wound Care, edited by D. Krasner (Health Management Publications, Inc., King of Prussia, PA 1990), pp. 240-246.
Lavery, Lawrence, et al: "Emerging Concepts with VAC Therapy"; vol. 20, Publication date Jul. 1, 2007, Issue No. 7.
Merriam OnLine definitions-"occlusive", "occlude" and "occluding". *
Merriam OnLine definitions—"occlusive", "occlude" and "occluding". *
New Zealand Examination Report dated Aug. 27, 2007; New Zealand Patent Application No. 544731.
Non-Final Office Action date mailed May 27, 2010 for U.S. Appl. No. 12/006/566.
Non-Final Office Rejection date mailed Apr. 27, 2010 for U.S. Appl. No. 12/069,245.
Notice of Allowance date mailed Oct. 1, 2010 for U.S. Appl. No. 12/069,245.
PCT International Search Report; PCT international application PCT/US04/23541; Feb. 18, 2005.
PCT Written Opinion, PCT international application PCT/US04/23541, Feb. 18, 2005.
Response filed Jul. 19, 2010 for U.S. Appl. No. 12/069,245.
Response to non-final office action filed Aug. 26, 2010 for U.S. Appl. No. 12/006,566.
Response to Restriction Requirement filed Mar. 25, 2010 for U.S. Appl. No. 12/006,566.
Restriction Requirement date mailed Feb. 25, 2010 for U.S. Appl. No. 12/006,566.
S.E. Greer, et al.; The Use of Subatmospheric Pressure Dressing Therapy to Clos Lymphocutaneous Fistulas of the Groin; British Journal of Plastic Surgery (2000), 53, p. 484-487, Article No. BJPS2000.3360, Elsevier Sdence/The British Association of Plastic Surgeons, United Kingdom.
Singapore Search and Written Opinion (issued by Austrian Patent Office) date mailed Aug. 5, 2009; Singapore Patent Application No. 200804990-0.
V.A.C. Therapy Clinical Guidelines, A reference source for clinicians, Jul. 2007.
Venturi, "Mechanisms and Clinical Applications of the Vacuum-Assisted Closure (VAC) Device", Am J Clin Dermatol 2005: 6(3): 185-194.
WO2005009488A2 (en) 2005-02-03
JP5680544B2 (en) 2015-03-04 Device for delivering reduced pressure to the body surface
CN102770165B (en) 2016-07-06 Apparatus for negative pressure wound therapy
US8722960B2 (en) 2014-05-13 Systems and methods for wound protection and exudate management
JP4796230B2 (en) 2011-10-19 Wound treatment device that uses a vacuum
US8435221B2 (en) 2013-05-07 Closed incision negative pressure wound therapy device and methods of use
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WILKES, ROBERT;SANDERS, TERYL BLANE;REEL/FRAME:015099/0451;SIGNING DATES FROM 20040709 TO 20040713
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WILKES, ROBERT;SANDERS, TERYL BLANE;SIGNING DATES FROM 20040709 TO 20040713;REEL/FRAME:015099/0451